Andreas Alexandrou

Andreas Alexandrou

Auto-generated profile, based on publicly available information

Andreas Alexandrou

First Department of Surgery, National and Kapodistrian University of Athens, “Laikon” General Hospital, 115 27 Athens, Greece

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2010 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
TDTheodoros Diamantis
Theodoros Diamantis
AAAndreas Alexandrou
Andreas Alexandrou
NNNikolaos Nikiteas
Nikolaos Nikiteas
AGAthanasios Giannopoulos
Athanasios Giannopoulos
EPEustathios Papalambros
Eustathios Papalambros

3 December 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
NDNikoletta Dimitriou
Nikoletta Dimitriou
EFEvangelos Felekouras
Evangelos Felekouras
IKIoannis Karavokyros
Ioannis Karavokyros
AAAndreas Alexandrou
Andreas Alexandrou
Emmanouil PikoulisEmmanouil Pikoulis
Emmanouil Pikoulis
JGJohn Griniatsos
John Griniatsos
The incidence of colorectal cancer (CRC) is expected to increase by 80% in year 2035. Even though advantages in treatment of CRC have being made over the last decades, the outcome remains poor. Recently, several inflammatory markers including pretreatment neutrophil to lymphocyte ratio (NLR), have being used as prognostic factors, since host inflammatory response to cancer is believed to determine disease progression. The aim of this study is to evaluate the prognostic significance of pretreatment NLR, in terms of overall survival (OS), 5-year survival, disease-free survival (DFS) and recurrence, in CRC patients who underwent curative resection. We retrospectively reviewed 296 patients, who were submitted to elective surgery as first therapeutic option in curative intent, between January 2010 and December 2015. Pretreatment NLR, as well as demographics, clinical, histopathologic, and laboratory data were analyzed. Univariate and multivariate analyses were conducted to identify prognostic factors associated with OS, 5-year survival, DFS and recurrence. The cutoff point of NLR was calculated with Kaplan-Meier curves and log-rank test to 4.7. Univariate and multivariate analyses disclosed elevated NLR as a significant dismal prognostic factor for DFS (HR 1.88; 95% CI 1.01–3.52; p = 0.048), 5-year survival (HR 2.14; 95% CI 1.12–4.10; p = 0.021) and OS (HR 2.11; 95% CI 1.11–4.03; p = 0.023). In a subgroup analysis, in patients with stage II CRC, NLR > 4.7 was a stronger poor predictor for DFS (HR 2.76; 95% CI 1.07–7.13; p = 0.036), 5-year survival (HR 3.84; 95% CI 1.39–10.63; p = 0.01) and OS (HR 3.62; 95% CI 1.33–4.82; p = 0.012). After adjusting stage for gender, age, location of the primary tumor, differentiation, as well as the presence of perineural, vascular, and lymphovascular invasion, the significance of NLR > 4.7 became more prominent for DFS (HR 2.85; 95% CI 1.21–6.73; p = 0.0176), 5-year survival (HR 4.06; 95% CI 1.66–9.93; p = 0.002) and OS (HR 4.07; 95% CI 1.69–9.91; p = 0.002) in stage II patients. Pretreatment NLR > 4.7 is a poor prognostic factor for DFS, 5-year survival and OS in CRC patients undergoing curative resection. The dismal prognostic effect of NRL is magnified in Stage II CRC patients.

26 July 2012 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
AAA. Alexandrou
A. Alexandrou
EFE. Felekouras
E. Felekouras
AGA. Giannopoulos
A. Giannopoulos
CTC. Tsigris
C. Tsigris
TDT. Diamantis
T. Diamantis

14 May 2010 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
TDT. Diamantis
T. Diamantis
AAA. Alexandrou
A. Alexandrou
EPE. Pikoulis
E. Pikoulis
DDD. Diamantis
D. Diamantis
JGJ. Griniatsos
J. Griniatsos
EPE. Papalambros
E. Papalambros

30 December 2021 in In Vivo
Verified
Journal Article
Closed access
PDF file
AAAndreas Alexandrou
Andreas Alexandrou
PSPanagiotis Sakarellos
Panagiotis Sakarellos
SDSpyridon Davakis
Spyridon Davakis
MVMichail Vailas
Michail Vailas
NDNikoletta Dimitriou
Nikoletta Dimitriou
EFEvangelos Felekouras
Evangelos Felekouras
Inadequate weight loss or weight regain after Roux-en-Y gastric bypass (RYGBP) occurs in more than a quarter of patients for various reasons. Available remedying treatment options include endoscopic and surgical techniques for revision of the gastric pouch and the gastro-jejunal anastomosis, conversion of standard to distal gastric bypass (DRYGBP) or the conversion of RYGBP to biliopancreatic diversion (BPD) or duodenal switch (DS). There is quite a variability concerning the technical simplicity, safety, and effectiveness of these techniques and the small number of patients in the numerous single-center reports precludes any meaningful comparisons. This review aimed to describe all available methods and present the advantages and disadvantages of each of them, to facilitate, rather than guide, the decision of the average bariatric surgeon who encounters such a patient.

1 August 2015 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
ILIrene Lambrinoudaki
Irene Lambrinoudaki
EAEleni Armeni
Eleni Armeni
DRDemetrios Rizos
Demetrios Rizos
GGGeorgios Georgiopoulos
Georgios Georgiopoulos
FAFoteini Athanasouli
Foteini Athanasouli
KSKimon Stamatelopoulos
Kimon Stamatelopoulos
Objective We aimed to evaluate the association between thyroid hormones and indices of obesity in a sample of euthyroid postmenopausal women. Design Cross-sectional study. Methods Serum levels of TSH, free triiodothyronine (FT3), and free thyroxine (FT4) as well as BMI and waist:hip ratio (WHR) were evaluated in 194 healthy euthyroid postmenopausal women. Ultrasonography was used to assess abdominal fat layers (subcutaneous fat (SF), preperitoneal fat (PF), and SF:PF ratio). Indices of adiposity were defined as high vs low depending on the median value of the assessed parameters. Results After multivariate adjustment for traditional risk factors, lower FT4 levels and a higher FT3:FT4 ratio predicted higher SF mass (FT4, Exp(β)=0.035, P=0.020 and FT3:FT4, Exp(β)=2.374, P=0.018), whereas higher FT3 predicted higher PF mass (Exp(β)=2.815, P=0.032). Women with FT3:FT4 above the highest quartile had a significantly higher SF mass as compared to women in the lowest quartile (1.81±0.62 cm vs 1.54±0.46 cm, P=0.027). BMI had a positive independent association with TSH (Exp(β)=1.829, P=0.018). Finally, FT3 was significantly associated with SF mass among women with higher BMI (FT3, β=0.259, P=0.040) and women with higher WHR (β=0.309, P=0.020) but not among women with lower BMI or WHR values. Conclusion Thyroid hormone levels, and in particular FT3, were independently associated with SF and PF in euthyroid postmenopausal women, and this association was mainly evident in women with higher BMIs. On the other hand, among traditional indices of adiposity, only TSH was positively associated with BMI. Larger prospective studies are needed to evaluate the significance of the present findings.